Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives /

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.
Published: (2020)

Examining HRSA's oversight of the 340B Drug Pricing Program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017.
Published: (2018)

340B Drug Discount Program : information about hospitals that received an eligibility exception as a result of COVID-19.
Published: (2023)

Courts evaluate the role of contract phramacies in the 340B Drug Discount Program /
by: Rogers, Hannah-Alise
Published: (2022)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)

Requesting the President and directing the Secretary of Health and Human Services provide certain documents to the House of Representatives relating to estimates and analyses of the cost of the medicare prescription drug legislation : adverse report together with dissenting views (to accompany H.Res. 776) (including cost estimate of the Congressional Budget Office).
Published: (2004)

Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to congressional requesters.
Published: (2018)

Affordable prescriptions now : examining legislation to lower costs for seniors : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Fayette, Georgia, July 21, 2022.
Published: (2022)

Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997.
Published: (1997)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.
Published: (2022)

EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
Published: (2018)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Effects of medicare's drug pricing on other purchasers.
Published: (2007)

Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019.
Published: (2022)

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act /
by: Adams, Christopher P., et al.
Published: (2021)

Drug product selection : staff report to the Federal Trade Commission.

Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001.
Published: (2002)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study.
Published: (2010)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

Why does the United States pay, by far, the highest prices in the world for prescription drugs? : hearing of the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Eighteenth Congress, second session, on examining the cost of prescription drugs, February 8, 2024.
Published: (2024)

The role of pharmacy benefit managers in prescription drug markets : report prepared by the House Committee on Oversight and Accountability staff.
Published: (2024)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.
Published: (2023)

A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

A Status report : accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)